(Q30249813)

13 June 2017

1 reference

title

Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches (English)

1 reference

blastic plasmacytoid dendritic cell neoplasm

13 June 2017

main subject

0 references

Acute myeloid dendritic cell leukemia

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27264021%20AND%20SRC:MED&resulttype=core&format=json

Caterina Giovanna Valentini

7 June 2020

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27264021%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Sara Grammatico

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27264021%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Alessandro Pulsoni

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27264021%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

5 June 2016

1 reference

British Journal of Haematology

13 June 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27264021%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27264021%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27264021%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

188-202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27264021%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm.

7 June 2020

cites work

1 reference

TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow

21 January 2018

1 reference

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.

21 January 2018

1 reference

Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm

21 January 2018

1 reference

BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells.

21 January 2018

1 reference

Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents

21 January 2018

1 reference

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

21 January 2018

1 reference

Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?

21 January 2018

1 reference

Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity.

21 January 2018

1 reference

Neoplasms derived from plasmacytoid monocytes/interferon-producing cells: variability of CD56 and granzyme B expression

21 January 2018

1 reference

Neoplasms derived from plasmacytoid dendritic cells

21 January 2018

1 reference

High-dose chemotherapy supported by autologous stem cell transplantation in patients with primary central nervous system lymphoma: facts and opinions

21 January 2018

1 reference

Targeted diphtheria toxin to treat BPDCN.

21 January 2018

1 reference

Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients

21 January 2018

1 reference

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

21 January 2018

1 reference

Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?

21 January 2018

1 reference

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.

21 January 2018

1 reference

Blastic plasmacytoid dendritic cell leukemia successfully treated by autologous hematopoietic stem cell transplantation to a remission of 48-month duration

21 January 2018

1 reference

Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm

21 January 2018

1 reference

Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation--a single center experience

21 January 2018

1 reference

CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells

21 January 2018

1 reference

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

21 January 2018

1 reference

Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients

21 January 2018

1 reference

Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation

21 January 2018

1 reference

Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.

21 January 2018

1 reference

CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate

21 January 2018

1 reference

Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature

21 January 2018

1 reference

Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm

21 January 2018

1 reference

Cytarabine dose for acute myeloid leukemia

21 January 2018

1 reference

Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.

21 January 2018

1 reference

Novel markers of normal and neoplastic human plasmacytoid dendritic cells

21 January 2018

1 reference

Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile

21 January 2018

1 reference

SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms

21 January 2018

1 reference

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

21 January 2018

1 reference

Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasm.

21 January 2018

1 reference

A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm

21 January 2018

1 reference

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

21 January 2018

1 reference

What is CD4+CD56+ malignancy and how should it be treated?

21 January 2018

1 reference

Blastic plasmacytoid dendritic cell neoplasm with extensive cutaneous and central nervous system involvement

21 January 2018

1 reference

Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

21 January 2018

1 reference

Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm

21 January 2018

1 reference

Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement

21 January 2018

1 reference

Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.

21 January 2018

1 reference

21 January 2018

1 reference

Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review

21 January 2018

1 reference

WHO-EORTC classification for cutaneous lymphomas

21 January 2018

1 reference

Clinical and biologic features of CD4+CD56+ malignancies

21 January 2018

1 reference

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

21 January 2018

1 reference

Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm—Morphologic and Phenotypic Variability in a Series of 33 Patients

21 January 2018

1 reference

Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.14146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27264021%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference